Vecuronium Bromide for Injection Recalled By Sagent Over Patient Risk

Posted on

Vecuronium Bromide for Injection 10mg is being recalled by the Schaumburg, Illinois-based Sagent Pharmaceuticals due to an issue that has the potential to have a distinct impact on patient safety.  Three lots are affected by the recall, and each was provided to Sagent by MN Pharmaceuticals and then made available to hospitals and further distributors around the country between January and May of last year.  Given to patients  as a means to block neuromuscular function in the midst of mechanical ventilation or surgery, these products might be impure, an issue that could lead said neuromuscular blocking to be extended for those patients who suffer from a failed renal system.  Healthcare professionals are being asked to quarantine the affected lots and consumers are being asked to report adversity at once.  No such adverse situations have been reported at this time.

For more about the recall, follow this link.